Aortic Stenosis and Treatment with TAVR/SAVR
Aortic stenosis is one of the most common heart valve diseases encountered in clinical practice. New insights into the pathophysiology of patients with aortic stenosis, coupled with advances in imaging and interventions, are fueling interest in the management of this disease.
Please join us to hear Dr. Patrick T. O’Gara, a world-renowned speaker and a luminary in the field of cardiology and interventional and valvular heart disease, discuss the natural history of aortic stenosis and the evidence behind current guideline recommendations on strategies to optimize the timing and treatment modalities in the management of aortic stenosis.
Cardiologists, interventional cardiologists, cardiothoracic surgeons, vascular surgeons, interventional radiologists, echocardiographers, pulmonologists, hematologists, general internists, primary care physicians, intensivists, emergency medicine physicians, hospitalists, respiratory therapists (direct delivery), nurses, pharmacists and pharmacy technicians and other interested healthcare providers.
- Analyze the natural history of aortic stenosis and determine appropriate timing of valve interventions.
- Compare outcomes of TAVR vs. surgical AVR (SAVR).
- Analyze and assess situations in which SAVR might be preferred over TAVR.
Patrick T. O'Gara, M.D.
Director of Strategic Planning, Division of Cardiovascular Medicine
Watkins Family Distinguished Chair in Cardiology,
Brigham and Women’s Hospital
Professor of Medicine, Harvard Medical School
Patrick T. O'Gara, M.D., faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Elliott Elias, M.D., conference director for this activity, has indicated that he is on the speakers’ bureau for Abbott Laboratories, Bioventrix, Boston Scientific and Philips Healthcare.
All of the relevant financial relationships listed for this individual have been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 AMA PRA Category 1 Credit™
- 1.25 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.25 Florida Board of Pharmacy
- 1.00 Florida Board of Respiratory Therapy
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.